Vitrolife Q4: Below expectations
Sales in Q4 came in significantly lower than our forecast, affected by a negative currency effect. All market regions and business units showed growth in local currency, but high variance was seen between the different business units. Our forecast was expecting higher operating costs than what was reported, but EBIT was still lower than expected. Overall, the report was below expectations and confirmed our view that the company would have a hard time living up to the high set expectations in the near-term.